Last updated: 22 June 2019 at 3:26am EST

Christopher J Riopelle Net Worth




The estimated Net Worth of Christopher J Riopelle is at least $898 mil dollars as of 11 August 2008. Christopher Riopelle owns over 9,583 units of DaVita Inc stock worth over $898,224 and over the last 19 years Christopher sold DVA stock worth over $0.

Christopher Riopelle DVA stock SEC Form 4 insiders trading

Christopher has made over 2 trades of the DaVita Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently Christopher exercised 9,583 units of DVA stock worth $484,421 on 11 August 2008.

The largest trade Christopher's ever made was exercising 13,333 units of DaVita Inc stock on 26 November 2007 worth over $673,450. On average, Christopher trades about 3,274 units every 37 days since 2005. As of 11 August 2008 Christopher still owns at least 5,833 units of DaVita Inc stock.

You can see the complete history of Christopher Riopelle stock trades at the bottom of the page.



What's Christopher Riopelle's mailing address?

Christopher's mailing address filed with the SEC is 601 HAWAII STREET, , EL SEGUNDO, CA, 90245.

Insiders trading at DaVita Inc

Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler,, eKent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.



What does DaVita Inc do?

about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,



Complete history of Christopher Riopelle stock trades at DaVita Inc

Acionista maioritário
Trans.
Transação
Preço total
Christopher J Riopelle
Chief Compliance Officer
Exercício de opção $484,421
11 Aug 2008
Christopher J Riopelle
Chief Compliance Officer
Exercício de opção $673,450
26 Nov 2007


DaVita Inc executives and stock owners

DaVita Inc executives and other stock owners filed with the SEC include: